Related Experiment Video
Updated: Jun 6, 2026
08:23
Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens
Published on: March 10, 2020
Update on human Campylobacter jejuni infections
Beth D Kirkpatrick1, David R Tribble
1Infectious Disease Unit and Vaccine Testing Center, University of Vermont College of Medicine, Burlington, Vermont, USA. beth.kirkpatrick@uvm.edu
Current Opinion in Gastroenterology
|December 3, 2010
Summary
Human campylobacteriosis, caused by Campylobacter jejuni, presents challenges due to increasing antibiotic resistance and post-infectious complications. Future research priorities include vaccine development and understanding host immunity.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Campylobacteriosis is a significant global health burden, causing bacterial gastroenteritis.
- Campylobacter jejuni is a leading cause of foodborne illness worldwide.
- Understanding host immunity and bacterial factors is crucial for managing infections.
Purpose of the Study:
- To review recent clinical, epidemiological, and immunological advances in human campylobacteriosis.
- To highlight the evolving understanding of Campylobacter jejuni infections and their sequelae.
- To inform future research directions for prevention and management.
Main Methods:
- This review synthesizes current research on human campylobacteriosis.
- It incorporates findings from clinical observations, epidemiological studies, and immunological investigations.
- Human experimental infections are discussed as a method for studying immune responses and natural history.
Main Results:
- Increased recognition of Campylobacter jejuni's role in post-infectious sequelae.
- Growing understanding of disease burden and host-pathogen interactions.
- Rising fluoroquinolone resistance in C. jejuni complicates antibiotic management.
- Human experimental infections provide insights into immune responses and infection dynamics.
Conclusions:
- Campylobacter infections remain a high priority due to their significant health impact.
- Future research should focus on vaccine development and pathogen-specific immunity.
- Identifying risk factors for post-infectious sequelae is essential for improved patient outcomes.
Related Concept Videos
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:25Urinary Tract Infection II: Pathophysiology
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
01:23Stringent Response in E. coli
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
01:22Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...